Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine ...

The split between the AAP and the federal government highlights growing tensions in public health policy under the Trump ...

The landscape of COVID-19 vaccinations for children is shifting in the US. How will this affect the upcoming virus season?

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

Coronavirus infections are climbing again, marking another summer wave as children go back to school. But this uptick arrives ...

For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine ...

Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.

The American Academy of Pediatrics had earlier urged parents to get young children vaccinated against Covid — pushing back ...

Currently, children ages 5 to 11 are eligible for two pediatric doses of Pfizer's Covid-19 vaccine but are not yet eligible for a booster. Pfizer is testing a third dose in that age group now.

It's important to note, however, that Pfizer's vaccine requires two doses administered several weeks apart to reach 95% efficacy. So 100 million doses would vaccinate half the number of people.

Drugmaker Pfizer said Friday that as government contracts come to an end, possibly by early next year, its COVID-19 vaccine will be sold for $110 to $130 per dose.

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...